COVID-19 Drug Development

COVID-19 drug development is a research process to discover a preventative and therapeutic prescription of drugs that would control the severity of coronavirus disease. From 2020 to 2021, various drug companies, biotechnology firms, university research groups, and health organizations were started developing over 600 potential therapies for corona virus disease with various stages of preclinical or clinical research, with 391 therapeutic candidates in clinical trials, as of January 2021.

Committee Members
Speaker at Pharmaceutics and Drug Delivery Systems 2021 - Sergey Suchkov

Sergey Suchkov

Sechenov University and Moscow Engineering Physical Institute, Russian Federation
Speaker at Pharmaceutics and Drug Delivery Systems 2021 - Marino Nebuloni

Marino Nebuloni

Parma University, Italy
Speaker at Pharmaceutics and Drug Delivery Systems 2021 - Esmaiel Jabbari

Esmaiel Jabbari

University of South Carolina, United States
Speaker at Pharmaceutics and Drug Delivery Systems 2021 - Paul Millner

Paul Millner

University of Leeds, United Kingdom
PDDS 2021 Speakers
Speaker at Pharmaceutics and Drug Delivery Systems 2021 - Jan Versijpt

Jan Versijpt

University Hospital Brussels, Belgium
Speaker at Pharmaceutics and Drug Delivery Systems 2021 - Madhav Bhatia

Madhav Bhatia

University of Otago, New Zealand
Speaker at Pharmaceutics and Drug Delivery Systems 2021 - Stefanie Santos

Stefanie Santos

University Hospital Zurich, Switzerland
Speaker at Pharmaceutics and Drug Delivery Systems 2021 - Dmitry Ustyuzhanin

Dmitry Ustyuzhanin

National Medical Research Center of Cardiology, Russian Federation
Speaker at Pharmaceutics and Drug Delivery Systems 2021 - Anna Caprifico

Anna Caprifico

Kingston University, United Kingdom
Speaker at Pharmaceutics and Drug Delivery Systems 2021 - Annalisa Dalmoro

Annalisa Dalmoro

University of Salerno, Italy

Submit your abstract Today

Watsapp